Internal Medicine, Medical Oncology · Urbana, IL
NPI
1407955206
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
509 W. University Ave.
Urbana, IL, 61801
Phone (217) 383-6636
Groups this clinician bills Medicare through
Medicare paid, 2024
$78K
2,163 services
Medicare patients, 2024
251
Average age 73
Drug cost, 2024
$3.6M
2,738 prescriptions
Company payments, 2025
$273
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kendrith M Rowland was code 99214 (office e&m - established), 529 times for 125 patients. In total Kendrith M Rowland billed 2,163 services in 22 codes, and Medicare paid $78K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 529 | 125 | $67.43 | $36K |
| 99213 Office E&M - Established | Facility | 178 | 137 | $43.88 | $7,811 |
| 99204 Office E&M - New | Facility | 37 | 37 | $92.03 | $3,405 |
| 99214 Office E&M - Established | Office | 29 | 23 | $74.91 | $2,172 |
| 99232 Hospital E&M - Subsequent | Facility | 16 | 11 | $60.70 | $971 |
| 99213 Office E&M - Established | Office | 11 | 11 | $50.86 | $559 |
By year: 2022 $71K for 1,035 services; 2023 $71K for 1,400 services; 2024 $78K for 2,163 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kendrith M Rowland prescribed most often to Medicare patients was Tamoxifen Citrate, with 419 prescriptions and refills. In total Kendrith M Rowland wrote 2,738 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamoxifen Citrate Generic | 419 | 969 | 112 | $13K |
| Letrozole Generic | 211 | 551 | 63 | $5,608 |
| Ondansetron Odt Ondansetron | 143 | 143 | 100 | $1,367 |
| Prochlorperazine Maleate Generic | 137 | 137 | 89 | $1,353 |
| Anastrozole Generic | 133 | 273 | 40 | $1,887 |
| Prednisone Generic | 124 | 132 | 36 | $314 |
| Olanzapine Generic | 87 | 102 | 60 | $842 |
| Levothyroxine Sodium Generic | 64 | 146 | 20 | $472 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 57 | 57 | 30 | $1,811 |
| Ibrance Palbociclib | 56 | 56 | Under 11 | $894K |
| Gabapentin Generic | 50 | 72 | 12 | $817 |
| Omeprazole Generic | 45 | 73 | Under 11 | $343 |
| Potassium Chloride Generic | 45 | 69 | 20 | $843 |
| Amlodipine Besylate Generic | 40 | 100 | 15 | $377 |
| Eliquis Apixaban | 38 | 64 | 11 | $36K |
Brand drugs: - claims; generic drugs: 2,400 claims; opioid claims: 136.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kendrith M Rowland $273 ($273 in general payments such as food, travel and fees) from 10 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $109.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.